Knee Replacement Patients Enjoy Life-Changing Surgical Outcomes with RSIP Vision’s Revolutionary AI Solution

Innovative AI technology dramatically enhances speed and precision, resulting in greater comfort, easier recovery, and higher quality of life for patients

JERUSALEMMay 29, 2019 /PRNewswire/ — RSIP Vision, a global leader in artificial intelligence (AI), computer vision, and image processing technology, has announced the release of a new AI module that promises a life-changing impact on the millions of patients who undergo knee surgery every year. For most, knee replacement surgery is a difficult option, with a painful recovery and a long, rigorous rehabilitation period. Now the superior accuracy and precision of the RSIP Vision AI solution, unmatched in the market today, revolutionizes knee surgery to provide remarkably improved outcomes for patients. By helping surgeons match patients with the best possible implants, the groundbreaking technology offers patients far greater comfort, less pain, and a faster road to full mobility.

The innovative AI solution, developed explicitly for knee surgeries and based on advanced CT segmentation technology, represents a dramatic shift in the industry. Deployed by medical device companies, the AI technology supports doctors and radiologists with a faster, more exacting pre-operative process for knee replacement surgery—one of the most prevalent orthopedic surgeries in the U.S. today. Since implants often last for more than 20 years, the AI technology contributes to a knee patient’s higher quality of life for many years to come.

The new module is the first in a series of advanced solutions that RSIP Vision develops based on advanced AI segmentation and computer vision technologies. When integrated into the software environments of medical devices, these modules enhance capabilities and outcomes in various fields, including orthopedics, pulmonology, and cardiology. The AI modules solve complex technological challenges and add value to these vendor offerings by ensuring greater precision, shorter time to market, and lower costs.

Knee replacement, also called total knee arthroplasty (TKA), is a surgical option for patients with painful knee damage typically caused by arthritis or injury. Damaged cartilage and bone are removed from the knee joint and replaced with an implant made of metal, plastic, or ceramic. The new generation of AI technologies are trained on thousands of patient records to learn what different bones look like, streamlining and accelerating all aspects of the complex surgery for both radiologists and surgeons.

RSIP Vision’s new AI module enables radiologists to analyze patient’s CT scans far more efficiently, and produce exact measurements for every part of the body that makes contact with the implant. This type of precision is crucial to finding the right implant for each patient, whether choosing from a manufacturer’s selection or printing a personalized implant to match the knee perfectly. The module eliminates tedious effort and saves considerable time for radiologists, while also improving the speed and accuracy of their results.

This new AI technology also facilitates the planning process for surgeons, helping them find the right match for each implant and showing them exactly where to cut the bones. The AI results are applicable to robotic surgery as well, since they clearly define the correct regions for cutting bones and indicate boundaries for drilling, decreasing the risk of  harm to the patient.

“As AI grows increasingly essential to every industry, we’re dedicated to solving technology challenges for a wide range of businesses,” RSIP Vision founder and CEO Ron Soferman said. “In bringing our expertise in deep learning, image processing, and computer vision to knee replacement surgery, it’s particularly gratifying to know that our AI module makes a tremendous difference in patients’ comfort and safety during a very stressful experience.”

About RSIP Vision

RSIP Vision is a global leader in artificial intelligence, computer vision, and image processing technology. The company draws on a depth of knowledge and experience to provide customized services, sophisticated algorithms, and deep learning technology to businesses of all kinds, most notably medical devices, pharmaceuticals, and autonomous driving.

RSIP Vision develops practical AI modules that ensure precision, reduce time to market, cut costs, and free the core R&D team for other endeavors, saving significant time and money and giving businesses a real edge over the competition. RSIP Vision partners with customers on scientific research and development projects using customized algorithms in fields including physics, computer science, mathematics, biomedicine, and neuroscience.

RSIP Vision is headquartered in Jerusalem, with U.S. offices in San Jose, CA, and Boston, MA. More information is available on the company website:

Media Contact:
DeeDee Rudenstein


Related Links

About Peter Coffaro 506 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.